Virulence Systems of Human Pathogens as Targets for Novel Therapeutics and Prophylactics
A special issue of Biomolecules (ISSN 2218-273X). This special issue belongs to the section "Molecular Biology".
Deadline for manuscript submissions: closed (31 May 2021) | Viewed by 22288
Special Issue Editor
Interests: virulence systems; ATPases; inhibitors; vaccines
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Bacterial pathogens have specialized protein transport systems used to secrete toxins and deliver them to their intended targets. In the case of human pathogens, the proteins are mostly toxins that are designed to interfere with the host cell’s metabolism and general functioning. The predominant targets are cells of the immune system, where many components have their function disabled or severely interrupted by the secreted bacterial toxins.
There are at least nine secretory systems known in pathogens, and each one is highly conserved in the organization and mechanism of protein transport. Since many are not necessary for the pathogen’s survival outside the host but necessary for the infection, the secretory systems have become a point of interest for indirect antibacterial strategies targeting the function of systems, their assembly, and the mechanism of protein transport. Surprisingly, solutions designed against one pathogen are effective against a broader range of bacteria, which suggests that the strategy may deliver broad-spectrum antibacterials. Since the mechanism is different than for known commercial vaccines and antibiotics, the indirect-acting agents may offer a strategy to break the drug resistance barrier.
As enticing as it is, the approach has some potential problems. The pathogens are not directly destroyed by the compounds/proteins and require a functioning immune system of the host to defeat the attacking pathogen. In many immunocompromised patients, most frequently with underlying conditions related to weakened or compromised immune systems, the strategy alone may not work and would require additional help from direct-acting agents such as antibiotics. Therefore, the indirect-acting agents may be relegated to a secondary role unless converted to direct-acting drugs in the future.
Dr. Wiesław Świętnicki
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- secretory systems
- inhibitors
- system assembly
- protein transport
- animal models for indirect-acting therapeutics
- antibodies directed against the secretory systems
- small molecules
- structural components
- secretory ATPases
- human receptors for the toxins
- in silico approaches to understanding the mechanism of toxicity and protein transport mechanism
- human pathogens
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
